Korean J Otorhinolaryngol-Head Neck Surg.  2022 Dec;65(12):787-792. 10.3342/kjorl-hns.2022.00717.

Long-Term Oncologic Outcome of Transoral Laser Microsurgery for Early Glottic Cancer

• Lee SY
• Kwak JH
• Hong S
• Song CM
• Ji YB
• Tae K

• KMID: 2537333
• DOI: http://doi.org/10.3342/kjorl-hns.2022.00717

Abstract

Background and Objectives
Traditionally, transoral laser microsurgery (TLM) is commonly used to treat early glottic cancer. However, the long-term oncologic results have not been thoroughly investigated. Therefore, this study aimed to analyze long-term oncologic outcomes of TLM for early glottic cancer.
Subjects and Method
We retrospectively studied 132 patients who underwent TLM for early glottis cancer from January 2001 to August 2020. We assessed overall and disease-free survival according to the T classification and types of cordectomy proposed by the European Laryngological Society in 2007.
Results
Of the 132 patients, 125 were male and 7 female. The mean age was 61.6±9.3 years. We found 5 (3.8%), 112 (84.8%), and 15 (11.3%) patients staged as CIS, T1, and T2, respectively. For the cordectomy types, there were 6 in type I, 22 in type II, 83 in type III, 6 in type IV, 13 in type V, and 2 in type VI. Ten-year overall and disease-free survival rates were 99.2% and 87.1%, respectively. Overall and disease-free survival curves were not different according to different T classification and cordectomy types.
Conclusion
TLM is an excellent treatment modality for the long-term oncologic control of early glottic cancer.

Keyword

Laryngeal cancer; Laser surgery; Microsurgery; Survival rate